Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

AIMS: Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the diagnosis of pneumonia in patients presenting to emergency departments (EDs) with a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Maisel, Alan, Neath, Sean-Xavier, Landsberg, Judd, Mueller, Christian, Nowak, Richard M., Peacock, W. Frank, Ponikowski, Piotr, Möckel, Martin, Hogan, Christopher, Wu, Alan H.B., Richards, Mark, Clopton, Paul, Filippatos, Gerasimos S., Di Somma, Salvatore, Anand, Inder, Ng, Leong L., Daniels, Lori B., Christenson, Robert H., Potocki, Mihael, McCord, James, Terracciano, Garret, Hartmann, Oliver, Bergmann, Andreas, Morgenthaler, Nils G., Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Diagnosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284113/
https://www.ncbi.nlm.nih.gov/pubmed/22302662
http://dx.doi.org/10.1093/eurjhf/hfr177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284113/
https://www.ncbi.nlm.nih.gov/pubmed/22302662
http://dx.doi.org/10.1093/eurjhf/hfr177

Ejemplares similares